BRAF mutations in hairy-cell leukemia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
   Article
2. miR-520d-5p can reduce the mutations in hepatoma cancer cells and iPSCs-derivatives.BMC cancer · 2019
   Article
3. Pediatric low-grade gliomas: how modern biology reshapes the clinical field.Biochimica et biophysica acta · 2014
   Review
4. Hairy cell leukemia: short review, today's recommendations and outlook.Blood cancer journal · 2014
   Article
5. What are we learning from the cancer genome?Nature reviews. Clinical oncology · 2012
   Review

Corrections and comments

• Comment on
  BRAF mutations in hairy-cell leukemia.2011

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as